Jun 01, 2017 12:20 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...
Jun 01, 2017 12:20 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...
Jun 01, 2017 12:20 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...
Caladrius Biosciences to Participate at Upcoming June Conferences
Jun 01, 2017 12:20 pm UTC| Business
BASKING RIDGE, N.J., June 01, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a clinical stage development company with a cell therapy pipeline focused on immune modulation and select...
Jun 01, 2017 12:20 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...
Jun 01, 2017 12:20 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...
Jun 01, 2017 12:20 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...